(Q34715410)

4 August 2017

1 reference

title

Autoantibodies in autoimmune polyendocrine syndrome type II. (English)

1 reference

autoimmune polyendocrine syndrome

4 August 2017

1 reference

1 reference

Alberto Falorni

1

1 reference

PubMed ID

12092456

4 August 2017

Stefano Laureti

series ordinal

2

1 reference

PubMed ID

12092456

4 August 2017

Fausto Santeusanio

series ordinal

3

1 reference

4 August 2017

1 June 2002

1 reference

Endocrinology and Metabolism Clinics of North America

4 August 2017

1 reference

4 August 2017

31

1 reference

4 August 2017

2

1 reference

4 August 2017

369-89, vii

1 reference

Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers.

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Eighty-six cases of Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

The changing clinical spectrum of adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Auto-antibodies in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

STUDIES OF THE ADRENAL ANTIGENS AND ANTIBODIES IN ADDISON'S DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Immunologic aspects of adrenocortical insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

21-Hydroxylase, a major autoantigen in idiopathic Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

The natural history of adrenal function in autoimmune patients with adrenal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex. A clinical follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Low dose (1 mug) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Premature ovarian failure and ovarian autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Clinical Aspects of the Chronic form of Primary Adrenocortical Failure (Addison’s Disease) in the Adult

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Associated autoimmunity in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Organ-specific autoimmunity: a 1986 overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Thyroid autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Thyroid autoimmunity and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

1 reference

7 January 2021

Identification of tissue transglutaminase as the autoantigen of celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Autoimmune aspects of vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

Antibodies to tissue transglutaminase C in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2801%2900010-X

7 January 2021

10.1016/S0889-8529(01)00010-X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12092456